The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Global Vinpocetine for Injection Market Growth 2026-2032
US$ 3,660.00
The global Vinpocetine for Injection market size is predicted to grow from US$ 99 million in 2025 to US$ 142 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032. Vinpocetine fo...
May 2026
118 pages
Global Vinpocetine Drug Market Growth 2026-2032
US$ 3,660.00
The global Vinpocetine Drug market size is predicted to grow from US$ 148 million in 2025 to US$ 211 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032. Vinpocetine drug refer...
May 2026
125 pages
Global Injectable HIV Medication Market Growth 2026-2032
US$ 3,660.00
The global Injectable HIV Medication market size is predicted to grow from US$ 299 million in 2025 to US$ 827 million in 2032; it is expected to grow at a CAGR of 15.8% from 2026 to 2032. Injectable H...
May 2026
75 pages
Global Injectable HIV Treatment Market Growth 2026-2032
US$ 3,660.00
The global Injectable HIV Treatment market size is predicted to grow from US$ 296 million in 2025 to US$ 827 million in 2032; it is expected to grow at a CAGR of 15.8% from 2026 to 2032. Injectable HI...
May 2026
78 pages
Global Kallikrein Inhibitors Market Growth 2026-2032
US$ 3,660.00
The global Kallikrein Inhibitors market size is predicted to grow from US$ 2023 million in 2025 to US$ 4307 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032. Kallikrein inh...
May 2026
79 pages
Global Long-acting Anti-HIV Drugs Market Growth 2026-2032
US$ 3,660.00
The global Long-acting Anti-HIV Drugs market size is predicted to grow from US$ 295 million in 2025 to US$ 815 million in 2032; it is expected to grow at a CAGR of 15.8% from 2026 to 2032. Long-acting...
May 2026
82 pages
Global Esomeprazole Capsule Market Growth 2026-2032
US$ 3,660.00
The global Esomeprazole Capsule market size is predicted to grow from US$ 2592 million in 2025 to US$ 3921 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032. In 2025, global...
May 2026
107 pages
Postmenopausal Osteoporosis Treatment Market Forecasts to 2034 – Global Analysis By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents and Other Treatment Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Postmenopausal Osteoporosis Treatment Market is accounted for $9.8 billion in 2026 and is expected to reach $16.3 billion by 2034 growing at a CAGR of 6.6% dur...
May 2026
200 pages
Sulphonamides Market Forecasts to 2034 – Global Analysis By Type (Sulfamethoxazole, Sulfadiazine, Sulfacetamide, Sulfasalazine, Sulfadoxine and Other Types), Formulation, Route of Administration, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Sulphonamides Market is accounted for $141.53 million in 2026 and is expected to reach $245.00 million by 2034 growing at a CAGR of 7.1% during the forecast pe...
May 2026
200 pages
Global Cefixime Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Cefixime market size is expected to reach $ 191 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032). Cefixime API refers to the active pharmaceuti...
May 2026
117 pages
Global Josamycin API Market Growth 2026-2032
US$ 3,660.00
The global Josamycin API market size is predicted to grow from US$ 313 million in 2025 to US$ 475 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032. Josamycin API market refe...
May 2026
79 pages
